Green tea (Camellia sinensis) for the prevention of cancer
- PMID: 19588362
- PMCID: PMC6457677
- DOI: 10.1002/14651858.CD005004.pub2
Green tea (Camellia sinensis) for the prevention of cancer
Update in
-
Green tea (Camellia sinensis) for the prevention of cancer.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3. Cochrane Database Syst Rev. 2020. PMID: 32118296 Free PMC article.
Abstract
Background: Tea is one of the most commonly consumed beverages worldwide. Teas from the plant Camellia sinensis can be grouped into green, black and oolong tea. Cross-culturally tea drinking habits vary. Camellia sinensis contains the active ingredient polyphenol, which has a subgroup known as catechins. Catechins are powerful antioxidants. It has been suggested that green tea polyphenol may inhibit cell proliferation and observational studies have suggested that green tea may have cancer-preventative effects.
Objectives: To critically assess any associations between green tea consumption and the risk of cancer incidence and mortality.
Search strategy: We searched eligible studies up to January 2009 in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Amed, CancerLit, Psych INFO and Phytobase and reference lists of previous reviews and included studies.
Selection criteria: We included all prospective, controlled interventional studies and observational studies, which either assessed the associations between green tea consumption and risk of cancer incidence or that reported on cancer mortality.
Data collection and analysis: At least two review authors independently applied the study criteria, extracted data and assessed methodological quality of studies. Due to the nature of included studies, which were mainly epidemiological, results were summarised descriptively according to cancer diagnosis.
Main results: Fifty-one studies with more than 1.6 million participants were included. Twenty-seven of them were case-control studies, 23 cohort studies and one randomised controlled trial (RCT).Twenty-seven studies tried to establish an association between green tea consumption and cancer of the digestive tract, mainly of the upper gastrointestinal tract, five with breast cancer, five with prostate cancer, three with lung cancer, two with ovarian cancer, two with urinary bladder cancer one with oral cancer, three further studies included patients with various cancer diagnoses.The methodological quality was measured with the Newcastle-Ottawa scale (NOS). The 9 nested case-control studies within prospective cohorts were of high methodological quality, 13 of medium, and 1 of low. One retrospective case-control study was of high methodological quality and 21 of medium and 5 of low.Results from studies assessing associations between green tea and risk of digestive tract cancer incidence were highly contradictory. There was limited evidence that green tea could reduce the incidence of liver cancer. The evidence for esophageal, gastric, colon, rectum, and pancreatic cancer was conflicting. In prostate cancer, observational studies with higher methodological quality and the only included RCT suggested a decreased risk in men consuming higher quantities green tea or green tea extracts. However, there was limited to moderate evidence that the consumption of green tea reduced the risk of lung cancer, especially in men, and urinary bladder cancer or that it could even increase the risk of the latter. There was moderate to strong evidence that green tea consumption does not decrease the risk of dying from gastric cancer. There was limited moderate to strong evidence for lung, pancreatic and colorectal cancer.
Authors' conclusions: There is insufficient and conflicting evidence to give any firm recommendations regarding green tea consumption for cancer prevention. The results of this review, including its trends of associations, need to be interpreted with caution and their generalisability is questionable, as the majority of included studies were carried out in Asia (n = 47) where the tea drinking culture is pronounced. Desirable green tea intake is 3 to 5 cups per day (up to 1200 ml/day), providing a minimum of 250 mg/day catechins. If not exceeding the daily recommended allowance, those who enjoy a cup of green tea should continue its consumption. Drinking green tea appears to be safe at moderate, regular and habitual use.
Conflict of interest statement
None known
Comment in
-
Green tea for the prevention of cancer.J Evid Based Med. 2010 Feb;3(1):53. doi: 10.1111/j.1756-5391.2010.01063.x. J Evid Based Med. 2010. PMID: 21349042 No abstract available.
Similar articles
-
Green tea (Camellia sinensis) for the prevention of cancer.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3. Cochrane Database Syst Rev. 2020. PMID: 32118296 Free PMC article.
-
Cancer prevention by green tea: evidence from epidemiologic studies.Am J Clin Nutr. 2013 Dec;98(6 Suppl):1676S-1681S. doi: 10.3945/ajcn.113.058271. Epub 2013 Oct 30. Am J Clin Nutr. 2013. PMID: 24172305 Free PMC article.
-
Green tea polyphenols and cancer chemoprevention of genitourinary cancer.Am Soc Clin Oncol Educ Book. 2013:92-6. doi: 10.14694/EdBook_AM.2013.33.92. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714466 Review.
-
Dietary flavonoid for preventing colorectal neoplasms.Cochrane Database Syst Rev. 2012 Aug 15;(8):CD009350. doi: 10.1002/14651858.CD009350.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895989 Review.
-
White and green teas (Camellia sinensis var. sinensis): variation in phenolic, methylxanthine, and antioxidant profiles.J Food Sci. 2010 Aug 1;75(6):C541-8. doi: 10.1111/j.1750-3841.2010.01705.x. J Food Sci. 2010. PMID: 20722909
Cited by
-
Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre.JNMA J Nepal Med Assoc. 2023 Oct 1;61(266):782-786. doi: 10.31729/jnma.8309. JNMA J Nepal Med Assoc. 2023. PMID: 38289768 Free PMC article.
-
A Mendelian randomization study of the effect of tea intake on breast cancer.Front Nutr. 2022 Oct 18;9:956969. doi: 10.3389/fnut.2022.956969. eCollection 2022. Front Nutr. 2022. PMID: 36330145 Free PMC article.
-
Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database.Sci Rep. 2022 Aug 19;12(1):14178. doi: 10.1038/s41598-022-17704-z. Sci Rep. 2022. PMID: 35986023 Free PMC article.
-
Senescence-Mediated Redox Imbalance in Liver and Kidney: Antioxidant Rejuvenating Potential of Green Tea Extract.Int J Environ Res Public Health. 2021 Dec 27;19(1):260. doi: 10.3390/ijerph19010260. Int J Environ Res Public Health. 2021. PMID: 35010518 Free PMC article.
-
Catechins from oolong tea improve uterine defects by inhibiting STAT3 signaling in polycystic ovary syndrome mice.Chin Med. 2020 Nov 30;15(1):125. doi: 10.1186/s13020-020-00405-y. Chin Med. 2020. PMID: 33292347 Free PMC article.
References
References to studies included in this review
-
- Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High‐Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One‐Year Proof‐of‐Principle Study. Cancer Research 2006;66(2):1234. - PubMed
-
- Bonner MR, Rothman N, Mumford JL, He X, Shen M, Welch R, et al. Green tea consumption, genetic susceptibility, PAH‐rich smoky coal, and the risk of lung cancer. Mutation Research 2005;582(1‐2):53‐60. - PubMed
-
- Chyou PH, Nomura AM, Stemmermann GN. A prospective study of diet, smoking, and lower urinary tract cancer. Annals of Epidemiology 1993;3(3):211‐6. - PubMed
-
- Fujino Y, Tamakoshi A, Ohno Y, Mizoue T, Tokui N, Yoshimura T. Prospective study of educational background and stomach cancer in Japan. Preventive Medicine 2002;35(2):121‐7. - PubMed
-
- Galanis DJ, Kolonel LN, Lee J, Nomura A. Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. International Journal of Epidemiology 1998;27(2):173‐80. - PubMed
References to studies excluded from this review
-
- Arts IC, Hollman PC, Bueno De Mesquita HB, Feskens EJ, Kromhout D. Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. International Journal of Cancer 2001;92(2):298‐302. - PubMed
-
- Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF, et al. Tea consumption and risk of bladder and kidney cancers in a population‐based case‐control study. American Journal of Epidemiology 2000;151(4):377‐83. - PubMed
-
- Chyou PH, Nomura AM, Stemmermann GN. Diet, alcohol, smoking and cancer of the upper aerodigestive tract: a prospective study among Hawaii Japanese men. International Journal of Cancer 1995;60(5):616‐21. - PubMed
-
- Hara N, Sakata K, Nagai M, Fujita Y, Hashimoto T, Yanagawa H. Statistical analyses on the pattern of food consumption and digestive‐tract cancers in Japan. Nutrition and Cancer 1984;6(4):220‐8. - PubMed
Additional references
-
- Ahmad N, Hasan M. Green tea polyphenols and cancer: biological mechanisms and practical implications. Nutrition Review 1999;3:78‐83. - PubMed
-
- Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. European Journal of Cancer Prevention 2003;12(5):383‐90. - PubMed
-
- Blumenthal M. The ABC Clinical Guide to Herbs. Published by the American Botanical Council, 2003.
-
- Borrelli F, Capasso R, Russo A, Ernst E. Systematic review: Green tea and gastrointestinal cancer risk. Alimentary Pharmacology & Therapeutics 2004;19(5):497‐510. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources